Yang Runkuan, Tenhunen Jyrki, Tonnessen Tor Inge
Department of Intensive Care Medicine, Tampere University Hospital, University of Tampere, 10 Biokatu, 33014 Tampere, Finland; Department of Critical Care Medicine, University of Pittsburgh Medical School, 3550 Terrace Street, Pittsburgh, PA 15261, USA; Department of Emergencies and Critical Care, Oslo University Hospital, 4950 Nydalen, 0424 Oslo, Norway.
Department of Intensive Care Medicine, Tampere University Hospital, University of Tampere, 10 Biokatu, 33014 Tampere, Finland; Department of Surgical Science, Anesthesiology and Intensive Care Medicine, Uppsala University, 751 85 Uppsala, Sweden.
Int J Inflam. 2017;2017:1817564. doi: 10.1155/2017/1817564. Epub 2017 Feb 21.
Severe acute pancreatitis (SAP) starts as a local inflammation of pancreatic tissue that induces the development of multiple extrapancreatic organs dysfunction; however, the underlying mechanisms are still not clear. Ischemia-reperfusion, circulating inflammatory cytokines, and possible bile cytokines significantly contribute to gut mucosal injury and intestinal bacterial translocation (BT) during SAP. Circulating HMGB1 level is significantly increased in SAP patients and HMGB1 is an important factor that mediates (at least partly) gut BT during SAP. Gut BT plays a critical role in triggering/inducing systemic inflammation/sepsis in critical illness, and profound systemic inflammatory response syndrome (SIRS) can lead to multiple organ dysfunction syndrome (MODS) during SAP, and systemic inflammation with multiorgan dysfunction is the cause of death in experimental SAP. Therefore, HMGB1 is an important factor that links gut BT and systemic inflammation. Furthermore, HMGB1 significantly contributes to multiple organ injuries. The SAP patients also have significantly increased circulating histones and cell-free DNAs levels, which can reflect the disease severity and contribute to multiple organ injuries in SAP. Hepatic Kupffer cells (KCs) are the predominant source of circulating inflammatory cytokines in SAP, and new evidence indicates that hepatocyte is another important source of circulating HMGB1 in SAP; therefore, treating the liver injury is important in SAP.
重症急性胰腺炎(SAP)起始于胰腺组织的局部炎症,可导致多个胰腺外器官功能障碍;然而,其潜在机制仍不清楚。缺血再灌注、循环炎症细胞因子以及可能的胆汁细胞因子在SAP期间对肠道黏膜损伤和肠道细菌移位(BT)有显著影响。SAP患者循环中的高迁移率族蛋白B1(HMGB1)水平显著升高,且HMGB1是介导(至少部分介导)SAP期间肠道BT的一个重要因素。肠道BT在危重病中触发/诱导全身炎症/脓毒症方面起关键作用,而严重的全身炎症反应综合征(SIRS)在SAP期间可导致多器官功能障碍综合征(MODS),且伴有多器官功能障碍的全身炎症是实验性SAP的死亡原因。因此,HMGB1是连接肠道BT和全身炎症的一个重要因素。此外,HMGB1对多器官损伤有显著影响。SAP患者循环中的组蛋白和游离DNA水平也显著升高,这可反映疾病的严重程度并导致SAP中的多器官损伤。肝库普弗细胞(KCs)是SAP中循环炎症细胞因子的主要来源,新证据表明肝细胞是SAP中循环HMGB1的另一个重要来源;因此,治疗肝损伤在SAP中很重要。